tryptophan has been researched along with Central Nervous System Neoplasm in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alekar, S; Cloughesy, T; Desjardins, A; Lassman, AB; Li, R; Reardon, DA; Rixe, O; Taylor, CT; Williams, JH | 1 |
| Platten, M; Weller, M; Wick, W | 1 |
| Fülöp, F; Klivényi, P; Szalárdy, L; Toldi, J; Vécsei, L; Veres, G; Zádori, D | 1 |
| Barger, GR; Bosnyák, E; Juhász, C; Kamson, DO; Klinger, NV; Michelhaugh, SK; Mittal, S | 1 |
| Catapano, D; D'Agruma, L; D'Angelo, VA; Guarnieri, V; Muscarella, LA; Zelante, L | 1 |
2 review(s) available for tryptophan and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Shaping the glioma immune microenvironment through tryptophan metabolism.
Topics: Animals; Central Nervous System Neoplasms; Glioma; Humans; Tryptophan | 2012 |
Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).
Topics: Animals; Central Nervous System Neoplasms; Cognition Disorders; Drug Design; Enzyme Inhibitors; Humans; Kynurenine; Neurodegenerative Diseases; Patents as Topic; Structure-Activity Relationship; Tryptophan | 2016 |
1 trial(s) available for tryptophan and Central Nervous System Neoplasm
| Article | Year |
|---|---|
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Central Nervous System Neoplasms; Female; Glioma; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Kynurenine; Male; Middle Aged; Neoplasm Recurrence, Local; Succinimides; Treatment Outcome; Tryptophan; Young Adult | 2020 |
2 other study(ies) available for tryptophan and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.
Topics: Aged; Biomarkers, Tumor; Carbon Radioisotopes; Central Nervous System Neoplasms; DNA Methylation; ErbB Receptors; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Prognosis; Promoter Regions, Genetic; Tryptophan | 2017 |
Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
Topics: Adult; Aged; Arginine; Central Nervous System Neoplasms; DNA Mutational Analysis; Exons; Female; Hemangioblastoma; Humans; Leucine; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Biology; Mutation, Missense; Proline; Retrospective Studies; Tryptophan; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2005 |